Nomura Holdings’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,900
Closed -$1.43M 1883
2026
Q1
$1.43M Buy
+4,900
New +$1.61M ﹤0.01% 1034
2020
Q4
Sell
-30,500
Closed -$8.2M 1553
2020
Q3
$8.2M Sell
30,500
-158,300
-84% -$42.6M 0.02% 394
2020
Q2
$49.6M Buy
+188,800
New +$50.4M 0.17% 83
2017
Q4
Sell
-70,000
Closed -$13.3M 1554
2017
Q3
$13.3M Buy
+70,000
New +$13.3M 0.03% 319
2014
Q4
Sell
-10,800
Closed -$1.28M 2393
2014
Q3
$1.28M Sell
10,800
-9,200
-46% -$1.06M ﹤0.01% 1327
2014
Q2
$2.15M Buy
20,000
+13,200
+194% +$1.36M ﹤0.01% 1099
2014
Q1
$678K Buy
+6,800
New +$615K ﹤0.01% 1634

Other funds holding ELV

Nomura Holdings's ELV Position: Q2 2026 in Review

Nomura Holdings increased its Elevance Health (ELV) stake by 1,681% in Q2 2026, buying an estimated $4.67M and bringing the position to 13,343 shares worth $5.16M. The position accounts for 0.01% of the portfolio, ranked #778.

Nomura Holdings first reported a position in ELV in Q2 2013 and has held it in 46 quarters since. The position peaked at $63.8M in Q3 2020. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Nomura Holdings held 13,343 shares of Elevance Health worth $5.16M as of Q2 2026.
  • Nomura Holdings bought 12,594 Elevance Health shares in Q2 2026, an estimated $4.67M.
  • Elevance Health made up 0.01% of Nomura Holdings's portfolio in Q2 2026, its #778 holding.
  • Nomura Holdings first reported a position in Elevance Health in Q2 2013 and has held it in 46 quarters since.
  • Nomura Holdings's Elevance Health position peaked at $63.8M in Q3 2020.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.